FDA Grants Priority Review to Genentech’s Lucentis® Supplemental Biologics License Application for Myopic Choroidal Neovascularization
CORRECTION - Domestic Metals Engages ICP Securities Inc. for Automated Market Making Services and provides further details on the engagement of Michael Pound